Technical Analysis for EYPT - EyePoint Pharmaceuticals, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Down | Up | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Volume Surge | Other | 0.00% | |
Calm After Storm | Range Contraction | 0.00% | |
Earnings Movers | Other | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Jack-in-the-Box Bullish | Bullish Swing Setup | -0.69% | |
Calm After Storm | Range Contraction | -0.69% | |
Inside Day | Range Contraction | -0.69% | |
Wide Bands | Range Expansion | -0.69% | |
Upper Bollinger Band Touch | Strength | -0.69% | |
MACD Bullish Signal Line Cross | Bullish | -5.45% |
Alert | Time |
---|---|
Upper Bollinger Band Resistance | about 13 hours ago |
60 Minute Opening Range Breakout | about 16 hours ago |
Up 5% | about 16 hours ago |
Up 3% | about 16 hours ago |
Up 2% | about 16 hours ago |
Get this analysis on your stocks daily!
- Earnings date: 10/30/2024
EyePoint Pharmaceuticals, Inc. Description
EyePoint Pharmaceuticals, Inc., a specialty biopharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases. The company's lead product is ILUVIEN for the treatment of diabetic macular edema; and product candidate is YUTIQ, a non-erodible fluocinolone acetonide insert for the treatment of non-infectious posterior uveitis that is in the Phase III clinical trials. It also offers Retisert (fluocinolone acetonide intravitreal implant), a sustained-release implant for the treatment of posterior segment uveitis. In addition, the company has developed DEXYCU (dexamethasone intraocular suspension), an intraocular product for the treatment of postoperative ocular inflammation; and Vitrasert (ganciclovir), a sustained release implant for the treatment of cytomegalovirus retinitis. Further, it develops YUTIQ shorter-actinguveitis for the treatment of posterior segment uveitis; and Durasert tyrosine kinase inhibitor for the treatment of wet age-related macular degeneration. Additionally, the company's development program focuses on developing sustained release products using its Durasert and Verisome technology platforms to deliver drugs to treat chronic diseases. It sells its products primarily in the United States and Europe. The company has strategic collaborations with Alimera Sciences, Inc., Bausch & Lomb, and Enigma Therapeutics Limited. The company was formerly known as pSivida Corp. and changed its name to EyePoint Pharmaceuticals, Inc. in March 2018. EyePoint Pharmaceuticals, Inc. was founded in 1987 and is headquartered in Watertown, Massachusetts.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Eye Inflammation Organic Compounds Ophthalmic Macular Degeneration Suspension Tyrosine Kinase Chronic Disease Eye Diseases Macular Edema Wet Age Related Macular Degeneration Diabetic Macular Edema Uveitis Glucocorticoids Retinitis Ophthalmic Product Ophthalmic Products Pregnanes Cytomegalovirus Retinitis Diketones Fluocinolone Treatment Of Eye Diseases
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 30.99 |
52 Week Low | 5.855 |
Average Volume | 735,031 |
200-Day Moving Average | 14.84 |
50-Day Moving Average | 9.10 |
20-Day Moving Average | 9.94 |
10-Day Moving Average | 10.78 |
Average True Range | 1.02 |
RSI (14) | 62.55 |
ADX | 30.37 |
+DI | 38.68 |
-DI | 12.97 |
Chandelier Exit (Long, 3 ATRs) | 10.94 |
Chandelier Exit (Short, 3 ATRs) | 10.83 |
Upper Bollinger Bands | 12.39 |
Lower Bollinger Band | 7.49 |
Percent B (%b) | 0.81 |
BandWidth | 49.37 |
MACD Line | 0.66 |
MACD Signal Line | 0.53 |
MACD Histogram | 0.1369 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 13.65 | ||||
Resistance 3 (R3) | 13.71 | 13.03 | 13.29 | ||
Resistance 2 (R2) | 13.03 | 12.48 | 13.01 | 13.16 | |
Resistance 1 (R1) | 12.25 | 12.13 | 12.64 | 12.19 | 13.04 |
Pivot Point | 11.57 | 11.57 | 11.77 | 11.55 | 11.57 |
Support 1 (S1) | 10.79 | 11.02 | 11.18 | 10.73 | 9.88 |
Support 2 (S2) | 10.11 | 10.67 | 10.09 | 9.76 | |
Support 3 (S3) | 9.33 | 10.11 | 9.64 | ||
Support 4 (S4) | 9.27 |